AUPH
Aurinia Pharmaceuticals Inc.
15.80
1 x 13.91
1 x 18.30
bid
ask
-
1.17
6.89%
1 @ 08:30 AM
15.90 +0.10 (0.63%)
| Ytd | -0.94% | |
| 1y | 111.23% |
15.78
day range
17.12
7.36
52 week range
19.25
| Open | 16.97 | Prev Close | 16.97 | Low | 15.78 | High | 17.12 | Mkt Cap | 2.03B |
| Vol | 2.02M | Avg Vol | 1.41M | EPS | 2.16 | P/E | 7.31 | Forward P/E | 14.13 |
| Beta | 1.43 | Short Ratio | 7.72 | Inst. Own | 60.26% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 07-30 | 50-d Avg | 15.99 | 200-d Avg | 14.78 | 1yr Est | 17.00 |
| Income Statement | |||
| Total Revenue | 77.71M | ||
| Revenues (USD) | 77.71M | ||
| Cost of Revenue | 6.51M | ||
| Gross Profit | 71.20M | ||
| Operating Expenses | 29.78M | ||
| Research and Development Expense | 7.47M | ||
| Selling, General and Administrative Expense | 22.03M | ||
| Operating Income | 41.42M | ||
| Interest Expense | 1.01M | ||
| Income Tax Expense | 9.57M | ||
| Net Income | 34.35M | ||
| Net Income Common Stock | 34.35M | ||
| Net Income Common Stock (USD) | 34.35M | ||
| Consolidated Income | 34.35M | ||
| Earnings per Basic Share | 0.26 | ||
| Earnings per Basic Share (USD) | 0.26 | ||
| Earnings per Diluted Share | 0.25 | ||
| Earning Before Interest & Taxes (EBIT) | 44.94M | ||
| Earning Before Interest & Taxes (USD) | 44.94M | ||
| Weighted Average Shares | 132.38M | ||
| Weighted Average Shares Diluted | 137.64M | ||
| Balance Sheet | |||
| Cash and Equivalents | 41.01M | ||
| Cash and Equivalents (USD) | 41.01M | ||
| Investments | 337.78M | ||
| Investments Current | 337.78M | ||
| Trade and Non-Trade Receivables | 49.18M | ||
| Current Assets | 480.24M | ||
| Property, Plant & Equipment Net | 73.15M | ||
| Total Assets | 724.00M | ||
| Debt Current | 18.14M | ||
| Total Debt | 68.64M | ||
| Current Liabilities | 86.56M | ||
| Debt Non-Current | 50.50M | ||
| Total Liabilities | 156.37M | ||
| Accumulated Retained Earnings (Deficit) | -615.01M | ||
| Accumulated Other Comprehensive Income | -880.00K | ||
| Shareholders Equity | 567.63M | ||
| Shareholders Equity (USD) | 567.63M | ||
| Assets Non-Current | 243.75M | ||
| Total Debt (USD) | 68.64M | ||
| Deferred Revenue | 17.45M | ||
| Goodwill and Intangible Assets | 3.59M | ||
| Inventory | 46.41M | ||
| Liabilities Non-Current | 69.82M | ||
| Trade and Non-Trade Payables | 2.66M | ||
| Tax Assets | 166.92M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 4.82M | ||
| Net Cash Flow from Financing | -53.68M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -39.20M | ||
| Capital Expenditure | -39.00K | ||
| Issuance (Purchase) of Equity Shares | -35.45M | ||
| Issuance (Repayment) of Debt Securities | -3.65M | ||
| Net Cash Flow from Investing | -18.08M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | -18.04M | ||
| Net Cash Flow from Operations | 32.56M | ||
| Share Based Compensation | -866.00K | ||